Irreversible electroporation of pancreatic tumors

Martijn R. Meijerink, Anders Nilsson, Govindarajan Narayanan, Robert Martin

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Over 95% of pancreatic cancers are exocrine tumors that bare a dismal prognosis. Although oncological outcome is best for patients presenting with nonmetastatic resectable disease, cure is rarely achieved [1]. Up to 40% of patients present with nonmetastatic disease that is considered unresectable due to vascular encasement (locally advanced pancreatic carcinoma or LAPC) [1, 2]. These patients are nowadays routinely offered systemic chemotherapy with or without radiotherapy. Irreversible electroporation (IRE) represents a promising new method for focal destruction of pancreatic tumors. Evidence to support its effectiveness is gradually surfacing.
Original languageEnglish
Title of host publicationIrreversible Electroporation in Clinical Practice
PublisherSpringer International Publishing
Pages167-190
ISBN (Electronic)9783319551135
ISBN (Print)9783319551128
DOIs
Publication statusPublished - 2017

Publication series

NameIrreversible Electroporation in Clinical Practice

Cite this

Meijerink, M. R., Nilsson, A., Narayanan, G., & Martin, R. (2017). Irreversible electroporation of pancreatic tumors. In Irreversible Electroporation in Clinical Practice (pp. 167-190). (Irreversible Electroporation in Clinical Practice). Springer International Publishing. https://doi.org/10.1007/978-3-319-55113-5_11